((1R,2R)-2-((Benzyloxy)methyl)cyclopropyl)methanol, 98%, 500mg

Microliter syringe GASTIGHT® series 1000, 1.0 ml, 1001 TLL, 1 piece

3-Cyclopropyl-5-(trifluoromethyl)benzoic acid, 250mg

N-ethyl-2-methyl-6-(piperazin-1-yl)pyrimidin-4-amine, 95.0%, 500mg

4-(Dimethylamino)benzylamine dihydrochloride, 95.0%, 25g

1-Oxa-9-azaspiro[5.5]undecane hydrochloride, 95.0%, 1g

6-Vinylpicolinaldehyde, 98%, 2g

1-(1-methyl-1H-pyrazol-3-yl)ethanone, 95.0%, 5g

(3S,11AR)-3-METHYL-5,7-DIOXO-2,3,5,7,11,11A-HEXAHYDROOXAZOLO[3,2-A]PYRIDO[1,2-D]PYRAZINE-8-CARBOXYLIC ACID, 95.0%, 25mg

methyl 5-(2-fluorophenyl)isoxazole-3-carboxylate, 95.0%, 2.5g

Folding hinge closure PP blue 28

2-(6-(Benzyloxy)-3-nitropyridin-2-yl)acetonitrile, 95%, 5g

2,5-Dioxopyrrolidin-1-yl 2,5,8,11,14,17,20,23-octaoxahexacosan-26-oate, 98%, 5g